arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Pulse Biosciences, Inc

PLSE Health Care Medical/Dental Instruments
$52.68
▲ +3.6% Today
as of Oct 22, 16:51 ET
Last 30 days -2.82% Sep 14 → Oct 22
$43.57 $46.69 $49.82 $52.94 $56.06 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$50.92
High
$53.67
Low
$50.00
Volume
$421,421
Avg Vol
$349,335
Mkt Cap
$3.5B
P/E (TTM)
—
Beta
—
52w High
$58.90
52w Low
$12.56
Div Yield
—
Shares Out
$71M

Recent Press Releases & News last 60 days · 17 items

Oct 22 · 20:05 PR Business Wire
Pulse Biosciences Schedules Third Quarter 2026 Financial Results Conference Call for November 5, 2026
Oct 17 · 22:11 Simply Wall St.
Pulse Biosciences (PLSE) Stock Fair Value Rises After Analyst Target Increases
Oct 14 · 11:46 MT Newswires
Pulse Biosciences Collaborates With Clayman Thyroid Center on Thyroid Nodule Treatment
▸ Show all 17 press releases & news Free account →

PLSE earnings at a glance

Pulse Biosciences, Inc (PLSE) is scheduled to report earnings on Wednesday, November 4, 2026 — in 12 days. Analysts expect earnings per share of -$0.35, compared with -$0.29 in the same quarter last year (-21%). The options market is pricing a move of about ±10.0% after the report, a range of roughly $47.41 to $57.95 from today's $52.68. Over its last 6 reports the stock rose the next day 3 times and fell 3, moving ±7.5% on average; after the most recent report on Aug 6, 2026 it moved +10.9%. That means options currently expect more movement than PLSE has typically delivered. PLSE beat the consensus EPS estimate in 3 of its last 5 reported quarters. Implied volatility is currently 85%. The share price of $52.68 sits near its 52-week high.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$13
$59
87% of range
Avg surprise (last 5)
+3.4%
Avg reaction (last 6)
+0.3%
50% positive
Latest IV / EM
85%
EM ±10.0% · $50 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.36$-0.33$-0.30$-0.28$-0.25 Actual $-0.25Actual $-0.28Est $-0.26Actual $-0.29Est $-0.31Actual $-0.26Est $-0.32Actual $-0.27Est $-0.32Actual $-0.36Est $-0.31 Mar/2025Jun/2025Sep/20258KMar/2026Jun/2026
Revenue vs Net Income Revenue Net income
$-25M$-18M$-12M$-6M$455,700 Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu Aug 6, 2026Jun/2026 $-0.36 $-0.31 -16.1% -10.7% +10.9% earnings
Mon May 4, 2026Mar/2026 $-0.27 $-0.32 +15.6% -8.0% -3.8% earnings
Thu Feb 19, 20268K 2026-02-19 $-0.26 $-0.32 +18.8% — -14.6% earnings
Wed Nov 5, 2025Sep/2025 $-0.29 $-0.31 +6.5% — -3.3% earnings
Tue Aug 12, 2025Jun/2025 $-0.28 $-0.26 -7.7% — +11.2% earnings
Thu May 8, 2025Mar/2025 $-0.25 — — — +1.3% earnings

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Wed Nov 4, 2026Sep/2026OTHER -$0.35-$0.29 -20.7%

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$434,000$401,000—$86,000$0$0—$0
Cost of revenue$273,000$370,000—$279,000$0$0—$0
Gross profit————————
Operating income$-25M$-19M—$-20M$-20M$-18M—$-14M
Net income$-25M$-19M—$-19M$-19M$-17M—$-13M
EPS (diluted)————————

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$102M$68M$81M$95M$106M$119M$118M$79M
Inventory$236,000$206,000$136,000$57,000$51,000$30,000$0—
Total current assets$106M$71M$83M$97M$108M$121M$119M$80M
Total assets$116M$82M$95M$109M$120M$133M$132M$93M
Long-term debt————————
Total liabilities$16M$15M$14M$16M$16M$15M$18M$14M
Total equity$100M$66M$81M$93M$104M$118M$115M$79M

Implied volatility — last 90 days

53%121%189%257%324% Jun 12 — IV 209% · EM ±21.3%Jun 19 — IV 88% · EM ±19.5%Jun 22 — IV 97% · EM ±20.2%Jun 23 — IV 103% · EM ±21.2%Jun 24 — IV 98% · EM ±19.5%Jun 25 — IV 106% · EM ±20.7%Jun 26 — IV 102% · EM ±19.6%Jun 29 — IV 97% · EM ±17.3%Jul 02 — IV 108% · EM ±17.5%Jul 03 — IV 112% · EM ±17.5%Jul 07 — IV 151% · EM ±20.0%Jul 08 — IV 141% · EM ±17.6%Jul 15 — IV 325% · EM ±19.2%Jul 20 — IV 83% · EM ±19.7%Jul 21 — IV 70% · EM ±16.2%Jul 22 — IV 75% · EM ±17.2%Jul 23 — IV 83% · EM ±18.7%Jul 24 — IV 86% · EM ±19.1%Jul 27 — IV 80% · EM ±16.8%Jul 28 — IV 82% · EM ±16.8%Jul 29 — IV 89% · EM ±17.8%Jul 30 — IV 91% · EM ±17.8%Jul 31 — IV 83% · EM ±15.8%Aug 03 — IV 98% · EM ±17.4%Aug 04 — IV 93% · EM ±16.1%Aug 05 — IV 80% · EM ±13.4%Aug 06 — IV 114% · EM ±18.5%Aug 07 — IV 82% · EM ±12.9%Aug 10 — IV 87% · EM ±12.0%Aug 11 — IV 93% · EM ±12.2%Aug 12 — IV 68% · EM ±8.5%Aug 13 — IV 96% · EM ±11.4%Aug 14 — IV 102% · EM ±11.2%Aug 17 — IV 158% · EM ±13.2%Aug 24 — IV 58% · EM ±12.0%Aug 25 — IV 59% · EM ±12.0%Aug 26 — IV 62% · EM ±12.5%Aug 27 — IV 54% · EM ±10.5%Aug 28 — IV 71% · EM ±13.6%Aug 31 — IV 66% · EM ±11.8%Sep 01 — IV 80% · EM ±13.9%Sep 02 — IV 60% · EM ±10.1%Sep 03 — IV 66% · EM ±10.7%Sep 04 — IV 74% · EM ±11.6%Sep 07 — IV 83% · EM ±11.6%Sep 08 — IV 93% · EM ±12.3%Sep 09 — IV 86% · EM ±10.8%Sep 10 — IV 87% · EM ±10.3%Sep 11 — IV 102% · EM ±11.2%Sep 14 — IV 135% · EM ±11.3%Sep 15 — IV 101% · EM ±7.3%Sep 16 — IV 171% · EM ±10.1%Sep 17 — IV 267% · EM ±11.2%Sep 21 — IV 77% · EM ±16.0%Sep 22 — IV 66% · EM ±13.6%Sep 23 — IV 71% · EM ±14.3%Sep 24 — IV 67% · EM ±13.1%Sep 25 — IV 60% · EM ±11.5%Sep 28 — IV 90% · EM ±15.9%Sep 29 — IV 71% · EM ±12.2%Sep 30 — IV 67% · EM ±11.2%Oct 01 — IV 65% · EM ±10.4%Oct 02 — IV 78% · EM ±12.2%Oct 06 — IV 78% · EM ±10.3%Oct 08 — IV 85% · EM ±10.0%

Sector peers

IRTC
iRhythm Holdings, Inc.
$3.5B $119.64+5.1%
NVST
Envista Holdings Corporation
$3.7B $23.97+4.3%
ICUI
ICU Medical, Inc.
$3.9B $168.33+4.5%
HTFL
Heartflow, Inc.
$4.3B $55.43-0.3%
ATRC
AtriCure, Inc.
$2.7B $59.30+2.8%
HAE
Haemonetics Corporation
$4.6B $116.16-1.7%

PLSE earnings FAQ

When is PLSE's next earnings date?

Pulse Biosciences, Inc is expected to report on November 4, 2026.

What is PLSE's expected move for earnings?

Options currently price a move of about ±10.0%, or $5.27 per share either way from $52.68.

How does PLSE stock usually react to earnings?

Across the last 6 reports the average next-day move was ±7.5%, up 3 times and down 3 times.

What EPS are analysts expecting from Pulse Biosciences, Inc?

The consensus estimate is -$0.35 per share, versus -$0.29 a year ago.

What is PLSE's implied volatility?

PLSE's at-the-money implied volatility is about 85% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in